You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中科生物(01237.HK)全年虧損收窄65.14%至6447.1萬元
格隆匯 03-30 21:03

格隆匯3月30日丨中科生物(01237.HK)發佈全年業績,截至2019年12月31日止年度,公司實現收入人民幣6.94億元,同比增長9.35%;年內虧損人民幣6447.1萬元,同比收窄65.14%;基本每股虧損人民幣0.104元;不派末期股息。

公告表示,北美市場仍然是集團最大的收入來源,佔集團總收入的48%(2018年:41%)。於本年度,來自北美市場的收入增長28.6%至人民幣3.344億元。隨着年內貿易緊張局勢的演變,儘管該市場的收入有所增長,但對集團出口至美國的產品被徵收高達25%的關税仍對盈利能力產生不利影響。

2020年1月29日,美國商務部宣佈啟動新的反傾銷税和反補貼税調查,以確定來自巴西和中國的木線條和木製品是否正在美國傾銷,並確定中國的生產商是否正在接收不公平的補貼。該集團出口到美國的某些木製品均屬於此類調查範圍。因此,集團將密切監察有關調查的發展,評估對集團的影響,並尋求必要和果斷的行動以儘量減少負面影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account